asp7962
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2013 (NCT01981928)
Timeline
Indications
Mechanism of action
- Nerve growth factor receptor Trk-AINHIBITOR
NTRK1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- asp7962
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02611466 | Phase 2 | Feb 16, 2016 | Astellas |
| NCT02136316 | Phase 1 | May 1, 2014 | Astellas |
| NCT01981928 | Phase 1 | Nov 1, 2013 | Astellas |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 3 | 3 | 2 | 2013 |
1 organizations
Page 1 / 1